Endurant Capital Management LP - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 103 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.5%.

Quarter-by-quarter ownership
Endurant Capital Management LP ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q1 2022$1,826,000
+118.4%
15,400
+153.7%
0.48%
+138.1%
Q4 2021$836,000
+117.1%
6,069
-18.9%
0.20%
+32.9%
Q1 2019$385,000
+38.5%
7,479
-27.4%
0.15%
+78.8%
Q4 2017$278,00010,3000.08%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q1 2018
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 450,422$6,251,85714.11%
Liontrust Investment Partners LLP 134,659$7,478,9610.13%
Birchview Capital, LP 7,365$1020.07%
FNY Investment Advisers, LLC 250$30.00%
FNY Investment Advisers, LLC 18$00.00%
FNY Investment Advisers, LLC 56$00.00%
McElhenny Sheffield Capital Management, LLC 31$4300.00%
Blue Trust, Inc. 65$100.00%
IFP Advisors, Inc 1$10.00%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders